SHIVA investigators. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial - Le Tourneau, C; Delord, J P; Gonçalves, A; Gavoille, C; Dubot, C; Isambert, N; Campone, M; Trédan, O; Massiani, M A; Mauborgne, C; Armanet, S; Servant, N; Bièche, I; Bernard, V; Gentien, D; Jezequel, P; Attignon, V; Boyault, S; Vincent-Salomon, A; Servois, V; Sablin, M P; Kamal, M; Paoletti, X (Lancet Oncol, 2015)